The influence of organic and inorganic chelators on the toxicity of bulk and nanoparticles of zinc oxide during germination and seedling growth of Nicotiana tabacum L.

Nano and bulk-forms of zinc oxide (ZnO) are used extensively in industry and consequently may accumulate in the environment. However, there is little information available on the comparative effects of these forms during the critical early stages of plant life. Furthermore, the role of chelating agents, which affect the bioavailability of metals, in ameliorating plant stress due to exposure to nano and bulk-forms of ZnO is not well characterised. In this study, the effects of different concentrations (0.5, 2.5, 5, 10, 50 and 100 ppm) of nano ZnO (22 nm) and bulk ZnO (natural form, 1000 nm) with and without organic (citrate) and inorganic (EDTA) chelators on germination and seedling growth, and oxidative stress markers of Nicotiana tabacum L. were compared. Chelators (without ZnO) enhanced root growth, whilst ZnO negatively affected seedling growth. ZnO toxicity was often mitigated by adding chelators, especially citrate, although at the highest levels (50 and 100?ppm) of ZnO, toxicity was more pronounced when chelated with EDTA, but was decreased with citrate. Collectively, our findings provide important information regarding the different morpho-physiological and biochemical effects of bulk and nano ZnO and organic and inorganic chelators (citrate and EDTA), which are all prevalent in the environment.     

Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle

Angiogenesis is an important process in cancer growth and metastasis. During the tumor angiogenic process, endothelial cells express various cell surface receptors which can be utilized for molecular imaging and targeted drug delivery. One such protein receptor of interest is the integrin alphav beta3. Our group is involved in the development of molecular imaging probes and drug delivery systems targeting alphav beta3. Based on extensive lead optimization study with the integrin antagonist compounds, we have developed a new generation of integrin alphav beta3 compound (IA) which has superior binding affinity to alphav beta3. Utilizing this IA as a targeting agent, we have developed a novel integrin-targeted nanoparticle (ITNP) system for targ alphav beta3 was observed. These ITNPs also were rapidly taken up by cells that express alphav beta3. The ITNPs accumulated in the angiogenic vessels, after systemic administration in a murine squamous cell carcinoma model. This novel intergrin targeted ITNP platform will likely have an application in targeted delivery of drugs and genes in vivo and can also be used for molecular imaging.     

Preparation and biomedical application of a non-polymer coated superparamagnetic nanoparticle

We report the preparation of a non-polymer coated superparamagnetic nanoparticle that is stable and biocompatible both in vitro and in vivo. The non-polymer, betaine, is a natural methylating agent in mammalian liver with active surface property. Upon systemic administration, the nanoparticle has preferential biodistribution in mammalian liver and exhibits good reduction of relaxivity time and negative enhancement for the detection of hepatoma nodules in rats using MRI. Our data demonstrate that the non-polymer coated superparamagnetic nanoparticle should have potential applications in biomedicine.     

Oligonucleotide-displaced organic monolayer-protected silver nanoparticles and enhanced luminescence of their salted aggregates

N-(2-mercaptopropionyl)glycine (tiopronin) monolayer-protected silver particles were partially displaced by single-stranded oligonucleotides through ligand exchanges. The oligonucleotide-displaced particles could be hybridized with complementary fluorophore-labeled oligonucleotides. Both the oligonucleotide-displaced and hybridized particles could be aggregated by electrostatic interactions with salt in buffer solution, and the aggregates displayed enhanced luminescence from fluorophores. This result suggests the possible application of surface-enhanced fluorescence from metallic nanoparticle aggregation for DNA detection.     

涡旋磁纳米颗粒——崭新的生物医用磁性纳米平台

相比于超顺磁性纳米颗粒,具有涡旋磁畴的磁性纳米颗粒,由于独特的磁化闭合分布、较大的粒径尺寸及外加磁场中的磁化翻转特性,使得其兼具弱的颗粒间磁相互作用和更优异的磁学性能,在生物医学领域展现出了更好的应用优势和潜力.本综述结合近年来国内外对涡旋磁畴的研究及涡旋磁纳米颗粒在生物医学领域的报道,提出了一类新型的生物医用涡旋磁溶胶体系,并以涡旋磁氧化铁纳米盘和纳米环为例,介绍了涡旋磁纳米颗粒的化学合成,并着重论述了这类具有独特涡旋畴结构的纳米颗粒在磁共振成像、抗肿瘤治疗等生物医学应用上的最新研究进展.     

聚合物纳米颗粒对动脉粥样硬化病变的影响及相关机理研究进展

聚合物纳米颗粒通常指基于疏水性聚合物的纳米粒子,由于其良好的生物相容性、高效的长循环特性以及优于其他纳米颗粒物的代谢排出方式等,在纳米医学领域中得到了广泛关注。现有研究证明聚合物纳米颗粒在心血管疾病,尤其是在动脉粥样硬化(atherosclerosis,AS)的诊断、治疗中具有独特的优点,已经成功地由基础研究向临床应用转化。但是聚合物纳米颗粒引起的炎症反应诱导泡沫细胞形成、巨噬细胞自噬,以及心血管系统疾病力学微环境改变引起的聚合物纳米颗粒富集等,都可能最终诱导AS的发生发展。在此,本文综述了近年来聚合物纳米颗粒在诊断、治疗AS疾病中的应用及其与AS病变的关系和机理,为后续研究利用聚合物纳米颗粒开发新型纳米药物治疗AS提供理论依据。     

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

1. Download : Download high-res image (201KB)
2. Download : Download full-size image

     

Solution Structures of Engineered Vault Particles

1. Download high-res image (271KB)
2. Download full-size image